Is bigger always better? Not necessarily.

Krystal Biotech is rated a 'Buy' due to strong Vyjuvek sales, robust profitability, and a promising pipeline. Read more on ...

Sana Biotechnology trades at a steep discount despite promising T1D assets UP421 and SC451. Check out why SANA stock is a buy ...

Rising U.S. interest rate expectations, highlighted by the St. Louis Fed hinting at possible hikes over the next 6 to 9 ...

Viking's weight loss pill program has a couple of issues, including the fierce competitors who have a big head start.

This week was -3.18% compared to the previous week...About two-thirds of the losses came from a biotech stock called 10x ...

Biotech firms are gaining major traction in 2026 due to the global pandemic. Take a look at some of the key features of ...

The company has tremendous prospects.

Currently, SXTC is trading at $6.60, up 456.59%. VERAXA Biotech develops next-generation antibody-based cancer therapies, including BiTAC T cell engagers and bispecific antibody-drug conjugates.The ...

The company's stock rose to a 52-week high of $9.35 on Wednesday. Last week, the company introduced the Fill-Tek Dispensing System for essential custom reagents, designed to ease bioprocessing ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...